HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $20.00 price target on the stock. Separately, Oppenheimer reissued an outperform rating and set a $14.00 price objective on shares of CalciMedica in a report […]
CalciMedica, Inc. (NASDAQ:CALC – Get Free Report) shares were down 5.6% on Tuesday . The company traded as low as $3.66 and last traded at $3.66. Approximately 16,938 shares were traded during mid-day trading, a decline of 8% from the average daily volume of 18,312 shares. The stock had previously closed at $3.87. Wall Street […]
PaxMedica’s (NASDAQ:PXMD – Get Rating) lock-up period will end on Wednesday, February 22nd. PaxMedica had issued 1,545,454 shares in its IPO on August 26th. The total size of the offering was $8,113,634 based on an initial share price of $5.25. After the expiration of the company’s lock-up period, major shareholders and company insiders will be […]